The pharmaceutical, insurance and hospital sectors of the health care industry are aggressively embracing process improvement techniques to reduce costs and to enhance customer satisfaction. In Canada, Germany, the UK and the USA, health care organizations employ techniques such as process automation, total quality management, process re-engineering and enterprise integration. These techniques have resulted in dramatic operational improvements in several cases, according to a new Financial Times Management Report.
Despite significant investment, the results of implementing process improvements within the health care industry have been mixed. For every success story, there is at least one disappointment - often arising from a lack of commitment, lack of resources, or a focus that is too broad, the report suggests.
On the other hand, within organizations that are willing to commit to the cultural change of process improvement, the results are quite positive. Across three sectors within the health care industry and four vastly different countries, health organizations are demonstrating that process improvement principles, which were originally developed in the manufacturing sector, are not only applicable to health care, but also critically important to performance, the report found, saying that the urgent need for continuous operational improvement across the three industry sectors suggest that the application of improvement techniques will expand within health care.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze